Exchange: NYSE·Updated 07:59 PM EDT
News
all
press releases
Pfizer's Next Weight-Loss Weapon: How Berobenatide Stacks Up Against Novo Nordisk's Wegovy and Eli Lilly's Zepbound
Key PointsPfizer's berobenatide appears to be a promising candidate that could challenge Wegovy and Zepbound...
Nasdaq News: Markets
More News
NVAX Q2 Earnings & Sales Beat Estimates, '26 Sales Outlook Raised
Novavax beat Q2 earnings and revenue estimates, raises its 2026 adjusted revenue outlook, cuts expense guidance and outlines potential Sanofi milestones ahead.
Zacks
PFE, MRK, SNY, MRNA In Focus As Trump Reportedly Eyes Executive Order On Vaccines And Autism
The order’s contents remain unclear, and timing could shift, Bloomberg reported, citing people familiar with the matter.
Stocktwits
Thursday 8/6 Insider Buying Report: PFE, GBFH
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys. On Wednesday, Pfizer's Director, Ronald E. Blaylock, made a $998,821 purchase of PF...
Nasdaq News: Markets
Moderna's mRNA Flu Vaccine Approved By FDA
Moderna's mRNA Flu Vaccine Approved By FDA Authored by Rachel Roberts via The Epoch Times, The U.S. Food and Drug Administration has approved Moderna's flu shot for over-50s, marking the first time the agency has licensed a messenger ribonucleic acid (mRNA) vaccine for seasonal...
Zero Hedge
Pfizer Q2 Earnings Call Highlights Non-COVID Growth and Cost Cuts
PFE raises its 2026 revenue outlook as non-COVID growth, deeper cost cuts and pipeline catalysts offset weaker COVID demand.
Zacks
Company News for Aug 5, 2026
Companies In The News Are: ALSN, CLX, AEIS, PFE.
Zacks
Pfizer, Merck, Amgen Double Down On Cancer And Send Takeover Buzz Around SLS And IBRX Into Overdrive
IBRX and SLS align with Big Pharma’s cancer push, fueling retail partnership and buyout speculation.
Stocktwits
Pfizer Says Monthly GLP-1 Candidate Could Rival Tirzepatide on Weight Loss
Pfizer stock rises after beating Q2 estimates and raising its 2026 revenue guidance to up to $62.5B. Get the key earnings takeaways.read more...
Benzinga
Pfizer repels Covid-19 sales tumble to raise 2026 guidance
Pfizer repels Covid-19 sales tumble to raise 2026 guidance...
Yahoo! Finance: News

Advertisement|Remove ads.